Stay updated on Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.

Latest updates to the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.7%
- Check44 days agoChange DetectedThe date for results posting has been updated to March 20, 2025, while the previous date for results submission of August 2, 2024, has been removed.SummaryDifference1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
Stay in the know with updates to Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Type 2 Diabetes and Kidney Disease Clinical Trial page.